SET Announcements | Interpharma Group (IP)

Trading Suspension and termination of listing status of IP-W1

Notification the final exercise and request for suspension of IP-W1

Report on the results of the Exercise of IP-W1 (F53-5)

Information Memorandum Description, Condition and Major Characteristics of Warrants of Inter Pharma Public Company Limited No. 2 (IP-W2)

SET adds new listed securities : IP-W2 to be traded on June 28, 2023

Resignation of Director

Changing of CFO

Report on the results of the sale of warrants offered to All common shares' shareholders (F53-5)

Notification the exercise of IP-W1 no. 7

Changing of Chief Accountant

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2023

Financial Statement Quarter 1/2023 (Reviewed)